Self-Expanding AV Valve Prosthesis With Ventricular Wall Anchoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing percutaneous heart valve replacement devices are unsuitable for tricuspid and mitral valves due to complex anatomy and fragile surrounding tissues, and radial force-dependent anchoring mechanisms risk annular disruption and atrioventricular nodal compression.

Innovation Solution

A self-expanding, non-thrombogenic, low-profile atrioventricular valve prosthesis with a flexible frame and a polymer valve structure, designed for percutaneous delivery via the venous system, anchored to the right ventricular endocardium or left ventricle, mimicking natural valve behavior.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If radial force-dependent anchoring mechanism is used, then device can be anchored to valve annulus, but annular disruption and atrioventricular nodal compression occur

Engineering Contradiction:
Improvedevice anchoringVSAvoidannular disruption and heart block
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces an intermediary anchoring mechanism that uses expandable arms with anchors engaging the ventricular wall rather than directly forcing the valve annulus. This mediator structure transfers the anchoring function from the vulnerable annulus to the more robust ventricular wall, preventing direct damage to the annulus and surrounding tissues while maintaining secure device positioning

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention replaces the traditional radial force mechanical anchoring system with a longitudinal expansion mechanism. Instead of applying outward radial pressure on the annulus, the device uses axial expansion of arms that engage the ventricular wall, fundamentally changing the mechanical approach from radial compression to longitudinal engagement, thereby eliminating annular disruption risks

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of operation

If percutaneous delivery approach is used, then open heart surgery is avoided, but device placement in tricuspid and mitral valves is difficult due to complex anatomy

Engineering Contradiction:
Improveavoid open heart surgeryVSAvoidcomplex anatomy navigation
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The device incorporates dynamic features including expandable arms and adjustable positioning mechanisms that allow the device to adapt to the complex three-dimensional anatomy of the tricuspid and mitral valves during deployment. The arms can dynamically adjust their position and angle to engage the ventricular wall at optimal points, navigating the anatomical complexity without requiring open surgery

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The percutaneous delivery system uses a nested configuration where the valve prosthesis is contained within a delivery catheter, which is guided through the venous system and across the valve. The device transitions from a compressed nested state during delivery to an expanded functional state at the implantation site, enabling minimally invasive access to complex valve locations

Inventive Principle:
Principle #7Nested doll (Nesting)

3Ease of operation

If self-expanding frame is used, then device can be delivered via catheter, but device profile is large

Engineering Contradiction:
Improvecatheter deliveryVSAvoiddevice profile
Core Design Contradiction:
Ease of operationVSLength of moving object

Solution Approach 1:

The device frame is segmented into multiple expandable arms or struts that can be compressed along the catheter axis for delivery and then expanded radially at the implantation site. This segmentation allows the device to transition from a low-profile linear configuration during delivery to a three-dimensional expanded structure for function, reducing the delivery profile while maintaining the required functional dimensions

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device can be securely placed in the tricuspid or mitral valve region without open heart surgery, mitigating heart block risks and providing durable, efficient valve replacement.

Implementation Method 1

a frame made from a flexible, self-expanding shape memory alloy

Methodology Applied
Scientific EffectShape memory effect: Shape Memory Alloy

Implementation Method 2

a frame made from a flexible, self-expanding shape memory alloy and superelastic material

Methodology Applied
Scientific EffectSuperelasticity: Pseudoelasticity

Data Source

PatentUS12564492B2Retrievable self-expanding non-thrombogenic low-profile percutaneous atrioventricular valve prosthesis
Publication Date: 2026.03.03 RI MED FOUND
  • US12564492B2 patent drawing
  • US12564492B2 patent drawing
  • US12564492B2 patent drawing

AI summary

An atrioventricular prosthesis device is provided. The device includes a frame at least partially defining and enclosing a central cavity, the frame having a distal portion, a proximal portion, and a middle portion connected therebetween. The device further includes a valve construct formed, at least in part, from a cell growth scaffold, at least partially disposed within the central cavity defined by the frame. The valve construct includes: an annular portion defining an aperture and being connected to the frame for positioning the valve construct within the central cavity of the frame, and a plurality of leaflets extending longitudinally and radially inward from the annular portion. The frame and valve construct are transitionable to a deployed state, in which a diameter of at least a portion of the frame and the valve construct substantially conform to a diameter of a tricuspid and/or mitral valve opening.